DermNet NZ

Ad

Authoritative facts about the skin from the New Zealand Dermatological Society Incorporated.

Neutrophilic dermatoses

Learning objectives
Introduction
Clinical features
Investigations
Management
Activity

Learning objectives

Introduction

Dermatoses with dense dermal infiltrates of neutrophils include:

Neutrophilic dermatoses are probably mediated through helper T cell type 1 cytokines (IL-2, INF-γ) rather than helper T cell type 2 cytokines (IL-4). This results in the stimulation of a cytokine cascade, which might be responsible for the local and systemic activation of neutrophils and histiocytes.

Clinical features

Acute febrile neutrophilic dermatosis

Acute febrile neutrophilic dermatosis or Sweet disease presents acutely as a rash accompanied by systemic symptoms. The skin lesions are rapidly evolving juicy often ‘pseudo-vesicular’ plaques or nodules accompanied by fever, leukocytosis, conjunctivitis and arthralgia. The lesions are most often located asymmetrically on the upper extremities, neck and face and may be painful. There may also be oral ulcers.

Acute febrile neutrophilic dermatosis arising on the back of the hands is sometimes called pustular vasculitis.

Acute febrile neutrophilic dermatosis may be idiopathic, or arise in association with:

Sweet disease Sweet disease Pustular vasculitis
Pustular vasculitis
Acute febrile neutrophilic dermatosis

Pyoderma gangrenosum

Pyoderma gangrenosum is associated with inflammatory bowel disease, rheumatoid arthritis and haematological malignancies but occasionally arises in otherwise healthy individuals.

Pyoderma gangrenosum results in acute and often severe ulceration characterised by an overhanging purple or black necrotic edge and severe pain. It most commonly arises on the lower legs but may appear on any site. It heals with cribriform scarring but may be very difficult to control.

Pyoderma gangrenosum
Superficial bullous PG
Pyoderma gangrenosum Pyoderma gangrenosum
Pyoderma gangrenosum (PG)

Investigations

Acute febrile neutrophilic dermatosis

Full blood count shows neutrophilia (and sometimes myelogenous leukaemia). Acute febrile neutrophilic dermatosis may be associated with an acute infection, so other investigations will depend on symptoms.

Skin biopsy characteristically shows:

Pyoderma gangrenosum

Diagnosis is made clinically. A skin biopsy is generally used to rule out other causes of skin ulceration. In pyoderma gangrenosum, the biopsy characteristically shows:

Direct immunofluorescence is generally negative.

It is important to culture a swab and if necessary, tissue from the ulcer for bacteria including slow growing mycobacteria and fungi.

Management

Acute febrile neutrophilic dermatosis

Acute febrile neutrophilic dermatosis may spontaneously resolve within two or three months, or more promptly with treatment of underlying infection or on withdrawal of the causative drug.

Treatment may also include:

These medications are usually very effective and only required for a few weeks. Sweet disease may however recur, in which case the treatment may be repeated.

Pyoderma gangrenosum

Pyoderma gangrenosum often requires one or more systemic immune suppressive medications and may recalcitrant to all drugs. Treatment may include:

Activity

Find out which drugs can precipitate acute febrile neutrophilic dermatosis.

Page 6 of 8. Next topic: Urticaria. Back to: Dermatological emergencies course contents.

Related information

On DermNet NZ:

Information for patients

Other websites:

Books about skin diseases:

See the DermNet NZ bookstore

Author: Clin Assoc Prof Amanda Oakley

DermNet does not provide an on-line consultation service.
If you have any concerns with your skin or its treatment, see a dermatologist for advice.